HOME >> BIOLOGY >> NEWS
School of Public Health awarded $30 million to develop and introduce pneumococcal vaccine

The Johns Hopkins Bloomberg School of Public is receiving $30 million dollars from the Global Alliance for Vaccines and Immunization (GAVI) and its financing arm, The Vaccine Fund, to accelerate the development and use of life-saving pneumococcal vaccines for children in the world's poorest countries. Through this public health effort, the School and its partners hope to prevent the deaths of nearly 2.2 million children between 2006 and 2020.

According to the World Health Organization, pneumococcal infections kill more than one million children each year, which is the same number that die from malaria. Most are infants and young children who die from pneumonia and meningitis. Immunizations are urgently needed because in many countries, up to 90 percent of pneumococcal strains are resistant to first-line antibiotics. Vaccines tailored to prevent the strains that are most prevalent in developing countries are in advanced stages of large-scale testing in Africa and Asia and should be available by 2006.

"In the past, life-saving vaccines have been slow to reach the children who need them the most. Nearly 15 years after Haemophilus influenzae type b vaccine was introduced in the United States and other rich countries, less than 10 percent of the children in the world's poorest countries receive this vaccine," explained Orin Levine, PhD, an associate with the School's Department of International Health. "Our aim is to work with national and international partners to accelerate this process by 10 years or more," said Dr. Levine.

The Pneumococcal Accelerated Development and Introduction Plan (ADIP) team at the Johns Hopkins Bloomberg School of Public Health, directed by Dr. Levine, will bring together experts from the public and private sectors. The team will coordinate efforts to address research, communications, supply, and financing issues that impede the uptake of the vaccine in developing countries. Establishing the burden of pneumococcal disease and the
'"/>

Contact: Tim Parsons
paffairs@jhsph.edu
410-955-6878
Johns Hopkins University Bloomberg School of Public Health
11-Feb-2003


Page: 1 2

Related biology news :

1. White House to honor UNC School of Medicine scientist for early career achievement
2. LSU Vet School receives $9.9 million for infectious disease research
3. Researchers in UGA Vet School discover a mechanism that blocks replication of a retrovirus
4. Dartmouth Medical School awarded $9 million grant for genomics research
5. Research news from Tufts University, Friedman School of Nutrition Science and Policy: February 2004
6. Mount Sinai School of Medicine conducting clinical trials with gene therapy for colorectal cancer
7. Harvard Medical School launches new department to study human biology at the level of whole systems
8. OXiGENE announces launch of ophthalmic clinical trial at The Johns Hopkins School of Medicine
9. Dartmouth Medical School geneticists discover new role for antisense RNA
10. School of public health launches CDC Center for Excellence in Environmental Public Health Tracking
11. Grant from Vetlesen Foundation supports URI Graduate School of Oceanography Climate Research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/6/2017)... 2017 Forecasts by Product Type ... by End-Use (Transportation & Logistics, Government & Public Sector, ... Fossil Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation ... Are you looking for a definitive report on the ... ...
(Date:4/3/2017)... 3, 2017  Data captured by IsoCode, ... detected a statistically significant association between the ... treatment and objective response of cancer patients ... predict whether cancer patients will respond to ... well as to improve both pre-infusion potency testing ...
(Date:3/28/2017)... PUNE, India , March 28, 2017 ... (Analog, IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), ... Maintenance), Vertical, and Region - Global Forecast to 2022", ... 30.37 Billion in 2016 and is projected to reach ... 15.4% between 2017 and 2022. The base year considered ...
Breaking Biology News(10 mins):
(Date:5/22/2017)... , ... May 22, 2017 , ... ... with other leaders of the Maryland Biohealth community in developing and issuing recommendations ... Top 3 U.S. BioHealth Innovation Hub by 2023. , The ...
(Date:5/21/2017)... (PRWEB) , ... May 20, 2017 , ... ... that helps avoid the lengthy trial and error process by finding the right ... It can also strengthen the doctor-patient relationship through a personalized approach to treatment. ...
(Date:5/18/2017)... ... May 18, 2017 , ... ... April 28, 2017 at the Prince Of Wales Private Hospital. The procedure was ... level C6-C7. The patient failed conservative treatments prior to undergoing surgery. , The ...
(Date:5/18/2017)... ... 17, 2017 , ... NDA Partners Chairman Carl Peck, MD , announced ... Laboratories and President of Pharmaceutical Development Business Unit of Cardinal Health, has joined the ... Health, he was former Chief Operating Officer at Anaborex, Senior VP and General Manager ...
Breaking Biology Technology:
Cached News: